Anti-CCR9 CAR T Cells for T Cell Leukaemia/Lymphoma — Stella

stellabeta Find trials matched to me Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Anti-CCR9 CAR T Cells for T Cell Leukaemia/Lymphoma — Stella

Recruiting

Back to T Cell Acute Lymphoblastic Leukemia trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(1 site)

United Kingdom

University College London Hospitals, London

Key details

Phase

First-in-human testing

Sponsor

University College, London

Collaborators

Great Ormond Street Hospital Charity, Medical Research Council

Enrollment target

~24 participants

Started

November 2025

Primary completion

December 2027

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov